Patent №
US 9,211,342
Granted
2015-12-15
Filed 2012
Owner
NOVO NORDISK HEALTHCARE AG
Lab
—
AI components
1
evo
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
13574128
The present invention relates to growth hormone (GH) compounds having additional disulphide bridges and at least one additional single point mutation making the compounds resistant to proteolytic degradation.
AI classification
Evolutionary computation0.91
Natural language0.03
Vision0.00
Machine learning0.00
AI hardware0.00
Speech0.00
Knowledge representation0.00
Planning0.00
Ownership
NOVO NORDISK HEALTHCARE AG
assignment · 293180066
Assignors
DEMUTH, HELLE, SCHIODT, CHRISTINE BRUUN, NOERSKOV-LAURITSEN, LEIF, CHEN, JIANHE, THYGESEN, PETER
On an employer assignment, the assignors are typically the inventors.